# Beyond the Eosinophil: Understanding the Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)

> **NCT05847452** · — · UNKNOWN · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 12 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Benralizumab

## Key facts

- **NCT ID:** NCT05847452
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-22
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05847452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05847452, "Beyond the Eosinophil: Understanding the Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05847452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*